Results 291 to 300 of about 355,709 (346)

First Report of <i>RET</i> Fusion-Positive Lung Adenocarcinoma With Miliary Intrapulmonary Metastases Responsive to Selpercatinib: A Case Report. [PDF]

Clin Case Rep
Iwanaka S, Nishimura T, Fujimoto H, Morita D, Kuru H, Sakakura Y, D'Alessandro-Gabazza CN, Yasuma T, Gabazza EC, Naito M, Ibata H, Kobayashi T.   +11 more
europepmc   +1 more source

Bioengineered Extracellular Vesicles in Emerging Cancer Vaccine Platforms

Small Science, EarlyView.
This review highlights recent advances in engineering extracellular vesicles (EVs) as next‐generation cancer vaccines. It outlines their biological roles and antigen‐presenting capacity, explores key strategies for antigen loading and delivery optimization, and summarizes preclinical and clinical applications using EVs from diverse immune and tumor ...
Wonkyung Ahn, Yeram Lee, Gi‐Hoon Nam, Jae Bem You, Eun Jung Lee   +4 more
wiley   +1 more source

Veratramine Inhibits Human Non-Small Cell Lung Cancer Cell Growth by Inhibiting the Hedgehog Signaling Pathway. [PDF]

J Pharmacopuncture
Lee SW, Kim HY, Kim W, Baek SM, Park JK, Park S, Han JE, Jo A, Seah E, Kim C, Lee J, Choi SK, Han S.   +12 more
europepmc   +1 more source

Exome‐wide molecular insights from blood and urine liquid biopsies in genitourinary cancers

UroPrecision, EarlyView.
Abstract Background Liquid biopsy has emerged as a non‐invasive method for real‐time cancer monitoring especially in genitourinary (GU) oncology. Most current studies utilize a panel‐based molecular profiling ranging from 50–600 genes; however, a comprehensive exome‐wide profiling of real‐world patient samples has been lacking. Methods Over 2000 liquid
Eric Jia, Tiantian Zheng, Yong Huang, Pan Du   +3 more
wiley   +1 more source

The efficacy analysis of neoadjuvant chemoimmunotherapy followed by surgery in stage III locally advanced non-small cell lung cancer: a systematic review and meta-analysis. [PDF]

BMC Cancer
Yang X, He Y, Guo T, Fang J, Chen S, Zhang Q, Lin Y, Xu N, Pan X, Li H.   +9 more
europepmc   +1 more source

The regulatory effects and applications of TIGIT/CD155 on the tumor microenvironment in HCC

VIEW, EarlyView.
Background The interaction between TIGIT and CD155 compromises immune cell efficacy in tumor targeting, potentially driving hepatocellular carcinoma (HCC) progression through diverse molecular pathways. What Was Done This study investigates the interplay between CD155 and TIGIT in regulating CD8+ T cell function and elucidates its implications in HCC ...
Wenting Li, Yukun Li, Yao Li, Mingqi Yang, Haichuan Peng, Hongwei Sun, Ping Jiang, Yizhun Zhu, Qiang Chen, Xiaobing Duan, Wei Zhao   +10 more
wiley   +1 more source

Immunoproteasome components LMP2, PSME1, and PSME2 as novel tissue biomarkers predicting response and survival in neoadjuvant chemoimmunotherapy for resectable NSCLC. [PDF]

Front Immunol
Xie R, Zhai K, Yu J, Zhao M.
europepmc   +1 more source

CircRNA in non‑small cell lung cancer: Potential biomarkers and therapeutic targets (Review). [PDF]

Mol Med Rep
Wu Z, Zhu Z, Zhao P, Song Y, Ke X.
europepmc   +1 more source

Machine learning and WGCNA reveal the PVT1/miR-143-3p/CDK1 ceRNA axis as a key regulator in NSCLC. [PDF]

Biochem Biophys Rep
Safarzadeh A, Ataei S, Sayad A, Ghafouri-Fard S.   +3 more
europepmc   +1 more source

Targeting tumor microenvironment with biomimetic nanovesicles for non-small cell lung cancer gene therapy. [PDF]

J Nanobiotechnology
Yan Q, Gong L, Tan Z, Liu Z, Li X, Liang D, Yang J, Zhang K, Dai S, Wang J.   +9 more
europepmc   +1 more source